thin endometrium
Conditions
Interventions
Medicine group:Estradiol valeratet
Sponsors
The Third Affiliated Hospital of Zhejiang Chinese Medical University
Eligibility
Sex/Gender
Female
Age
18 Years to 45 Years
Inclusion criteria
Inclusion criteria: (1) The age is between 18 and 45 years (including both ends); (2) Normal menstrual cycle, but hypomenorrhea or infertility; (3) There was no hormone therapy in the first 3 months; (4) No pregnancy preparation plan in the past six months; (5) Patients voluntarily participate in this study and can actively cooperate with the experimental process of the study; (6) Sign the informed consent form.
Exclusion criteria
Exclusion criteria: (1) younger than 18 years old or older than 45 years old. (2) Those with obvious uterine adhesion, uterine fibroids and other uterine cavity abnormalities and abnormal reproductive tract; (3) Complicated with serious internal medicine diseases, coagulation dysfunction and mental system diseases; (4) Poor compliance, failure to cooperate with treatment, and inability to tolerate patients examined in the course of this study; (5) Those who are participating in other clinical trials; (6) Refusing to sign the informed consent.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| endometrial thickness; | — |
Secondary
| Measure | Time frame |
|---|---|
| Menstrual blood loss;TCM Symptom Scale;Subendometrial blood flow parameters;estradiol; | — |
Countries
China
Contacts
Public ContactLifang Chen
The Third Affiliated Hospital of Zhejiang Chinese Medical University
Outcome results
None listed